United States· US:62135-969_3001c14d-1545-86fb-e063-6294a90a035f
Moexipril Hydrochloride
A moexipril product containing moexipril hydrochloride, registered in United States by Chartwell RX, LLC. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Moexipril is registered in 3 of 19 countries.
Countries holding a registration under ATC C09AA13 (moexipril), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Moexipril · ATC C09AA13
3 / 19 countries
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MOEXIPRIL HYDROCHLORIDE
- Manufacturer
- Chartwell RX, LLC
- Country
- United States (US)
- ATC code
- C09AA13
- ATC class
- Moexipril
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1162135-969-90
- ndc11621359699090 TABLET, FILM COATED in 1 BOTTLE (62135-969-90)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
238 interactions on record for moexipril.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Moexipril · interactions on record
238 records
- 11 severe
- 164 moderate
- 17 minor
- 25 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
21 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Moexipril in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/056b7493-fde5-441c-a7ef-d25f5ef5f2de GET /v1/drugs/056b7493-fde5-441c-a7ef-d25f5ef5f2de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "15",
"substance": "MOEXIPRIL HYDROCHLORIDE",
"productndc": "62135-969",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA077536",
"marketing_category": "ANDA"
}See everything about moexipril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.